Page last updated: 2024-12-05

cdaa

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

CDAA: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7157
CHEMBL ID2251312
CHEBI ID82170
SCHEMBL ID53540
MeSH IDM0053621

Synonyms (59)

Synonym
allidochlor [iso]
diallylchloroacetamide
rantox t
n,n-diallylchloroacetamide
nci-c04035
brn 1761616
alidochlor
alpha-chloro-n,n-diallylacetamide
einecs 202-270-7
hsdb 1560
cdaa
caswell no. 284
cdaat
alidochlore
acetamide, 2-chloro-n,n-diallyl-
2-chloro-n,n-di-2-propenylacetamide
n,n-diallyl-2-chloroacetamide
ai3-51490
diallylamid kyseliny chloroctove [czech]
allidochlor
acetamide, 2-chloro-n,n-di-2-propenyl-
cp 6,343
epa pesticide chemical code 019301
2-chloro-n,n-diallylacetamide
randox
acetamide, n,n-diallyl-2-chloro-
AKOS000202499
2-chloro-n,n-bis(prop-2-enyl)acetamide
2-chloro-n,n-bis(prop-2-en-1-yl)acetamide
F2158-1328
93-71-0
C19043
acetamide, 2-chloro-n,n-di-2-propen-1-yl-
diallylamid kyseliny chloroctove
2e0wf154qr ,
unii-2e0wf154qr
allidochlor [mi]
n,n-diallyl-.alpha.-chloroacetamide
cp-6343
.alpha.-chloro-n,n-diallylacetamide
allidochlor [hsdb]
SCHEMBL53540
chebi:82170 ,
CHEMBL2251312
radox
n-diallyl-2-chloroacetamide
DTXSID2041591
allidochlor, pestanal(r), analytical standard
AS-59792
FT-0716070
Q17310226
alidochlore; allidochlor; cdaa; cp 6,343;n,n-diallylchloroacetamide; randox
E79184
A859662
n,n-diallyl-2-chloro-acetamide
allidochlor 100 microg/ml in methanol
CS-0013971
EN300-08117
Z56899050

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"This analysis compared opioid-related adverse events (ORADEs) observed with fentanyl iontophoretic transdermal system (ITS) versus morphine intravenous (iv."( A comparison of opioid-related adverse events with fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia in acute postoperative pain.
Danesi, H; Ding, L; Grond, S; Jones, JB; Sinatra, RS; Viscusi, ER, 2016
)
0.43
" Treatment-emergent adverse events were collected via spontaneous report."( A comparison of opioid-related adverse events with fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia in acute postoperative pain.
Danesi, H; Ding, L; Grond, S; Jones, JB; Sinatra, RS; Viscusi, ER, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tertiary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a secondary amine; formula RC(=O)NHR(1)R(2).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1100793Binding affinity to SafBP receptor in Zea mays (maize) seedlings by [3H]Saf(R-29148) binding assay2000Journal of agricultural and food chemistry, Mar, Volume: 48, Issue:3
Comparative three-dimensional quantitative structure-activity relationship study of safeners and herbicides.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (13.79)29.6817
2010's5 (17.24)24.3611
2020's20 (68.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.56 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index5.56 (4.65)
Search Engine Demand Index92.22 (26.88)
Search Engine Supply Index2.07 (0.95)

This Compound (57.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.33%)5.53%
Reviews4 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]